LONDON, UK / ACCESSWIRE / July 18, 2016 / Active Wall St. announces the list of stocks for today’s coverage. Pre-market the Active Wall St. team provides the latest corporate, fundamental and technical events impacting selected stocks on the Oil & Gas Refining & Marketing industry. Companies recently under review include Western Refining, CVR Refining, Pacific Ethanol, and Ultrapar Participacoes. Register with us now for your free membership and more at:

http://www.activewallst.com/register/

Today, AWS is promoting its equity coverage. Get all of our research notes free by signing up to http://www.activewallst.com/register/.

Active Wall St. takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions. On Friday, July 15, 2016, the NASDAQ Composite ended the trading session at 5,029.59, down 0.09%; the Dow Jones Industrial Average edged 0.05% higher, to finish at 18,516.55; and the S&P 500 closed at 2,161.74, down 0.09%. The gains were broad based as five out of nine sectors ended the session in positive.

On Friday, shares in Western Refining Inc. which operates as an independent crude oil refiner and marketer of refined products, ended the session 2.24% lower at $19.62 with a total volume of 3.69 million shares traded.

Shares of the Company traded at a PE ratio of 5.62. The Company’s shares have advanced 1.03% in the last one month. The stock is trading 6.76% below its 50-day moving average. Moreover, shares of Western Refining have a Relative Strength Index (RSI) of 45.00. See our complete notes on WNR at: http://www.activewallst.com/registration-3/?symbol=WNR.

On Friday, shares in Sugar Land, Texas-based independent petroleum refiner and marketer of transportation fuels, CVR Refining L.P., recorded a trading volume of 990,029 shares, which was higher than their three months average volume of 655,410 shares.

The stock ended the day 4.59% lower at $6.23. Shares of the Company traded at a PE ratio of 5.21. The stock is trading below its 50-day moving average by 32.26%. Furthermore, shares of CVR Refining have an RSI of 22.04. CVRR free notes is just a click away at: http://www.activewallst.com/registration-3/?symbol=CVRR.

Pacific Ethanol Inc. produces and markets low-carbon renewable fuels in the United States. Pacific Ethanol Inc.’s stock finished Friday’s session 0.17% higher at $5.96 with a total volume of 357,994 shares traded. Over the last one month and the previous three months, the Company’s shares have gained 8.96% and 33.93%, respectively.

The stock is trading above its 50-day and 200-day moving averages by 11.39% and 24.57%, respectively. Pacific Ethanol’s stock has an RSI of 60.39. The Company was founded in 2003 and is headquartered in Sacramento, California. Sign up for your complimentary notes on PEIX at: http://www.activewallst.com/registration-3/?symbol=PEIX.

Ultrapar Participacoes S.A., through its subsidiaries, engages in the liquefied petroleum gas (LPG) distribution, fuel distribution, and related businesses. The stock closed the day flat at $21.87 with a total volume of 472,525 shares traded.

The Company’s shares have gained 9.30% in the last one month, 6.32% in the previous three months and 4.44% in the past one year. The stock is trading 7.18% and 22.78% above its 50-day and 200-day moving averages, respectively. Additionally, Ultrapar Participacoes’ stock traded at a PE ratio of 25.85 and has an RSI of 58.92. Register for free on Active Wall St. and access the latest notes on UGP at: http://www.activewallst.com/registration-3/?symbol=UGP.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442489

LONDON, UK / ACCESSWIRE / July 18, 2016 / Active Wall St. announces the list of stocks for today’s coverage. Pre-market the Active Wall St. team provides the latest corporate, fundamental and technical events impacting selected stocks on the CATV Systems industry. Companies recently under review include Liberty Global, Dish Network, TiVo Inc., and Liberty LiLAC. Register with us now for your free membership and more at:

http://www.activewallst.com/register/

Today, AWS is promoting its equity coverage. Get all of our research notes free by signing up to http://www.activewallst.com/register/.

Active Wall St. takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions. On Friday, July 15, 2016, the NASDAQ Composite ended the trading session at 5,029.59, down 0.09%; the Dow Jones Industrial Average edged 0.05% higher, to finish at 18,516.55; and the S&P 500 closed at 2,161.74, down 0.09%. The gains were broad based as five out of nine sectors ended the session in positive.

Liberty Global PLC, together with its subsidiaries, provides video, broadband Internet, fixed-line telephony, and mobile services in Europe, Chile, and Puerto Rico. The stock finished Friday’s session 1.11% lower at $31.26 with a total volume of 3.23 million shares traded.

The stock is trading below its 50-day moving average by 9.35%. Liberty Global’s stock has a Relative Strength Index (RSI) of 48.39. The Company was founded in 2004 and is based in London, the United Kingdom. LBTYA complete notes is just a click away at: http://www.activewallst.com/registration-3/?symbol=LBTYA.

On Friday, shares in Dish Network Corp. which together with its subsidiaries, provides pay-TV services in the U.S., ended the session 1.38% lower at $52.18 with a total volume of 1.53 million shares traded. Shares of the Company traded at a PE ratio of 30.89.

The Company’s shares have gained 16.92% in the previous three months. The stock is trading 3.60% above its 50-day moving average. Moreover, shares of Dish Network have an RSI of 54.18. The complimentary notes on DISH can be accessed at: http://www.activewallst.com/registration-3/?symbol=DISH.

TiVo Inc. provides video technology software services and cloud-based software-as-a-service solutions that enable viewers to consume content across various screens in and out-of-the home in U.S., Europe, and internationally. The stock edged 0.68% higher to close the day at $10.38 with a total volume of 880,853 shares traded.

The Company’s shares have gained 4.11% in the last one month and 9.61% in the past three months. Furthermore, the Company’s stock has advanced 0.48% in the previous one year. The stock is trading 4.33% and 15.68% above its 50-day and 200-day moving averages, respectively. Additionally, TiVo’s stock traded at a PE ratio of 55.21 and has an RSI of 67.61. Sign up for your complimentary notes on TIVO at: http://www.activewallst.com/registration-3/?symbol=TIVO.

On Friday, shares in Liberty LiLAC Group which provides various broadband services over cable distribution systems, and mobile services in Chile and Puerto Rico, recorded a trading volume of 1.34 million shares, which was higher than their three months average volume of 705,170 shares.

The stock ended the day 0.06% lower at $34.71. The stock is trading below its 50-day moving average by 8.92%. Furthermore, shares of Liberty LiLAC Group have an RSI of 44.01. Get free access to your notes on LILAK at: http://www.activewallst.com/registration-3/?symbol=LILAK.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442491

LONDON, UK / ACCESSWIRE / July 18, 2016 / Active Wall St. announces the list of stocks for today’s coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Diversified Machinery industry. Companies recently under review include ABB Ltd, Ingersoll-Rand, Donaldson, and Rockwell Automation. See our complete notes on ABB Ltd at:

http://www.activewallst.com/registration-3/?symbol=ABB

Today, AWS is promoting its equity coverage. Get all of our research notes free by signing up to http://www.activewallst.com/register/.

The Industrial Goods sector is once again in the limelight with investors as it is in the midst of a technological transformation. Given increased competition, industry operators are constantly improving factory performances and productivity. Let us see how these are affecting some of the big names in the industry. Register with us now for your free membership and more at:

http://www.activewallst.com/register/

Active Wall St. takes a brief technical look at how each of the companies mentioned above have fared following last Friday’s closing bell and over the last few trading sessions.

ABB Ltd (NYSE: ABB)

Zurich, Switzerland headquartered ABB Ltd’s shares finished 0.25% higher at $20.00 and with a total volume of 1.59 million shares traded. The stock has gained 2.41% in the last month, 5.20% in the previous three months, and 17.42% on an YTD basis. The Company’s shares are trading above their 50-day and 200-day moving averages by 1.75% and 10.22%, respectively. Moreover, shares of ABB, which provides power and automation technologies for utility and industrial customers globally, have a Relative Strength Index (RSI) of 59.05.

On July 15th, 2016, ABB wins First Commercial Order for Breakthrough 15-Second Flash Charging Technology to Enable Emission-Free Public Transport in Geneva to provide flash charging and on-board electric vehicle technology for 12 TOSA (Trolleybus Optimisation Systeme Alimentation) fully electric buses (e-buses) which will run on Line 23, connecting Geneva’s airport with suburban Geneva. The e-buses can help save as much as 1,000 tons of carbon dioxide per year. The Revolutionary technology requires no overhead lines and offers silent and zero-emission mass transit solution as a viable alternative to diesel buses, providing a model for future urban transportation.

Ingersoll-Rand PLC (NYSE: IR)

Shares in Swords, Ireland headquartered Ingersoll-Rand PLC ended Friday’s session 0.10% lower at $67.94 with a total volume of 1.56 million shares traded. The stock has advanced 5.63% in the last month, 7.06% over the previous three months, and 24.17% since the start of this year. The Company’s shares are trading 4.64% above their 50-day moving average and 16.74% above their 200-day moving average. Moreover, shares in Ingersoll-Rand, which designs, manufactures, sells, and services industrial and commercial products, have an RSI of 63.27.

On June 13th, 2016 Newsweek ranked Ingersoll Rand, a world leader in creating comfortable, sustainable and efficient environments, on its annual Green Rankings as one of 500 top green companies in the United States. The company ranks No. 59, realizing a 42-point improvement over the 2015 ranking. Sign up for your note on IR at:

http://www.activewallst.com/registration-3/?symbol=IR

Donaldson Co. Inc. (NYSE: DCI)

Minneapolis, Minnesota-based Donaldson Co. Inc.’s shares rose 0.20%, closing the session at $35.71 and with a total volume of 298,940 shares traded. The stock has gained 1.42% in the last one month, 11.06% over the previous three months, and 25.94% on an YTD basis. The Company’s shares are trading 4.73% above their 50-day moving average and 16.51% above their 200-day moving average. Additionally, shares of Donaldson Co., which manufactures and sells filtration systems and replacement parts globally, have an RSI of 60.56. Register for free and access your note on DCI at:

http://www.activewallst.com/registration-3/?symbol=DCI

Rockwell Automation Inc. (NYSE: ROK)

On Friday, shares in Milwaukee, Wisconsin headquartered Rockwell Automation Inc. closed the session 0.36% higher at $119.16. A total volume of 544,320 shares was traded. The stock has gained 3.10% in the last month, 2.62% over the previous three months, and 17.77% on an YTD basis. The Company’s shares are trading above their 50-day and 200-day moving averages by 3.65% and 12.01%, respectively. Furthermore, shares in Rockwell Automation, which provides industrial automation power, control, and information solutions, have an RSI of 59.27.

On June 9th, 2016, The Board of Directors of Rockwell Automation, Inc. declared a quarterly dividend of 72.5 cents per share on its common stock, payable on Sept. 12, 2016, to shareowners of record at the close of business on Aug. 15, 2016. The note on ROK is available for free at:

http://www.activewallst.com/registration-3/?symbol=ROK

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442502

LONDON, UK / ACCESSWIRE / July 18, 2016 / Active Wall St. announces the list of stocks for today’s coverage. Pre-market the Active Wall St. team provides the latest corporate, fundamental and technical events impacting selected stocks on the Textile – Apparel Clothing industry. Companies recently under review include V.F. Corp., Lululemon Athletica, G-III Apparel Group, and Carter’s. Register with us now for your free membership and more at:

http://www.activewallst.com/register/

Today, AWS is promoting its equity coverage. Get all of our research notes free by signing up to http://www.activewallst.com/register/.

Active Wall St. takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions. On Friday, July 15, 2016, the NASDAQ Composite ended the trading session at 5,029.59, down 0.09%; the Dow Jones Industrial Average edged 0.05% higher, to finish at 18,516.55; and the S&P 500 closed at 2,161.74, down 0.09%. The gains were broad based as five out of nine sectors ended the session in positive.

V.F. Corporation engages in the design, production, procurement, marketing, and distribution of branded lifestyle apparel, footwear, and related products in the U.S. and Europe. The stock lost 1.07% to close the day at $64.03 with a total volume of 2.39 million shares traded.

The Company’s shares have advanced 2.68% in the last one month and 0.50% in the past three months. The stock is trading 2.83% and 1.57% above its 50-day and 200-day moving averages, respectively. Additionally, V.F. Corp.’s stock traded at a PE ratio of 22.85 and has a Relative Strength Index (RSI) of 57.03. Visit us today and access our complete notes on VFC at: http://www.activewallst.com/registration-3/?symbol=VFC.

On Friday, shares in Vancouver, Canada-based athletic apparel company, Lululemon Athletica Inc., ended the session 0.49% higher at $77.80 with a total volume of 1.11 million shares traded. Shares of the Company traded at a PE ratio of 41.06.

The Company’s shares have gained 10.00% in the last one month, 20.06% in the previous three months and 23.92% in the past one year. The stock is trading 13.76% above its 50-day moving average and 30.60% above its 200-day moving average. Moreover, shares of Lululemon Athletica have an RSI of 77.35. The complimentary notes on LULU can be accessed at: http://www.activewallst.com/registration-3/?symbol=LULU.

On Friday, shares in G-III Apparel Group Ltd which designs, manufactures, and markets men’s and women’s apparel, ended the day 1.73% higher at $51.11 with a total volume of 475,521 shares traded. Shares of the Company traded at a PE ratio of 21.55.

The Company’s shares have gained 15.29% in the last one month and 10.48% in the previous three months. The stock is trading above its 50-day and 200-day moving averages by 20.24% and 6.44%, respectively. Furthermore, shares of G-III Apparel Group have an RSI of 75.93. Register for free on Active Wall St. and access the latest notes on GIII at: http://www.activewallst.com/registration-3/?symbol=GIII.

Carter’s Inc. and its subsidiaries design, source, and market branded childrenswear under the Carter’s, Child of Mine, Just One You, Precious Firsts, OshKosh, and other brands. The stock finished Friday’s session 0.72% higher at $108.85 with a total volume of 505,879 shares traded.

Over the last one month and the previous three months, the Company’s shares have advanced 5.16% and 4.93%, respectively. Furthermore, the Company’s stock has gained 4.60% in the past one year. The stock is trading above its 50-day and 200-day moving averages by 5.25% and 13.29%, respectively. Carter’s stock traded at a PE ratio of 23.59 and has an RSI of 62.04. Get free access to your notes on CRI at: http://www.activewallst.com/registration-3/?symbol=CRI.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442490

LONDON, UK / ACCESSWIRE / July 18, 2016 / Active Wall St. announces the list of stocks for today’s coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Property & Casualty Insurance industry. Companies recently under review include Old Republic International, Chubb, AmTrust Financial Services, and Cincinnati Financial. See our complete notes on Old Republic International at:

http://www.activewallst.com/registration-3/?symbol=ORI

Today, AWS is promoting its equity coverage. Get all of our research notes free by signing up to http://www.activewallst.com/register/

As the U.S. Property and Casualty Insurance space continues to face a wave of challenges, industry operators are looking at emerging markets for growth, broadening their assets, and increasing M&A activities. Let us see how these are affecting some of the big names in the industry. Register with us now for your free membership and more at:

http://www.activewallst.com/register/

Active Wall St. takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions.

Old Republic International Corp. (NYSE: ORI)

Last Friday, Chicago, Illinois-based Old Republic International Corp.’s stock saw a slight decline of 0.21%, to close the day at $19.47 with a total volume of 801,960 shares traded. The Company’s shares have advanced 5.36% in the last month, 7.62% in the previous three months, and 6.65% on an YTD basis. The stock is trading 2.97% above its 50-day moving average and 8.31% above its 200-day moving average. Additionally, shares of Old Republic International, which through its subsidiaries, engages in the insurance underwriting and related services business primarily in the U.S. and Canada, have a Relative Strength Index (RSI) of 60.23.

On June 6th, 2016 Old Republic Surety Company announced the addition of Chaz Cointment (quit-ma) as Bond Manager for its Kansas City, Kansas contract branch office located in Overland Park, Kansas.

Chubb Ltd (NYSE: CB)

Shares in Zurich, Switzerland headquartered Chubb Ltd saw a slight drop of 0.25%, finishing the session at $129.57. The stock recorded a trading volume of 1.07 million shares. The Company’s shares have gained 4.28% in the last month, 7.47% over the previous three months, and 11.51% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 2.69% and 10.59%, respectively. Furthermore, shares of Chubb, which provides property and casualty insurance and reinsurance products globally, have an RSI of 57.45.

On June 24th, 2016 Chubb received top honors at the 2016 Advisen Cyber Risk Awards in two categories: Cyber Risk Innovation of the Year and Pre-Breach Team of the Year. Now in its third year, the Advisen Cyber Risk Awards winners are determined by the largest number of votes received from members of the insurance community. The complimentary note on CB can be accessed at:

http://www.activewallst.com/registration-3/?symbol=CB

AmTrust Financial Services Inc. (NASDAQ: AFSI)

New York-based AmTrust Financial Services Inc.’s stock finished 0.31% lower at $25.32 last Friday at the close. A total volume of 860,971 shares was traded, which was above their three months average volume of 825,280 shares. The Company’s shares have advanced 2.20% in the past month and 1.51% in the previous three months. The stock is trading below its 50-day moving average by 0.19%. Additionally, shares of AmTrust Financial Services, which through its subsidiaries, underwrites and provides property and casualty insurance in the U.S. and globally, have an RSI of 57.11.

On June 16th, 2016 AmTrust Financial Services announced that it has acquired Total Program Management LLC (TPM) for cash. TPM is a managing general agency focused on programs that offer workers’ compensation insurance to the health care industry. In 2015, TPM was responsible for insurance premium totaling $47.1 million. Register for free and access the note on AFSI at:

http://www.activewallst.com/registration-3/?symbol=AFSI

Cincinnati Financial Corp. (NASDAQ: CINF)

Shares in Fairfield, Ohio headquartered Cincinnati Financial Corp. ended the session 1.04% lower at $75.96. The stock recorded a trading volume of 817,582 shares, which was above its three months average volume of 596,440 shares. The Company’s shares have surged 10.73% in the last month, 16.11% over the previous three months, and 30.22% on an YTD basis. The stock is trading 8.48% above its 50-day moving average and 21.94% above its 200-day moving average. Moreover, shares of Cincinnati Financial, which engages in the property casualty insurance business in the U.S., have an RSI of 70.39.

On July 14th, 2016 Cincinnati Financial Corp. announced that The Cincinnati Insurance Companies’ property casualty group expects its second-quarter results to include pretax catastrophe losses of approximately $160 million to $170 million, representing an impact on the second-quarter 2016 combined ratio of approximately 14.4% to 15.3%, based on estimated property casualty earned premiums.

On July 15th, 2016, research firm MKM Partners reiterated its ‘Buy’ rating with an increase of the target price to $90 a share from $80 a share for the Company’s stock. CINF free note is just a click away at:

http://www.activewallst.com/registration-3/?symbol=CINF

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442508

VANCOUVER, BC / ACCESSWIRE / July 18, 2016 / Klondike Gold Corp. (TSX.V: KG; FRA: LBDP) (“Klondike Gold” or the “Company”) announces that it has received payment from Rise Resources Inc. (“Rise”) for the acquisition by Rise of 100% of a portfolio of seven of Klondike’s British Columbia properties totalling 150 claims covering 128 square kilometers located in the southeastern part of the province (see News Release May 31, 2016). The seven properties are Red Point, Clubine, Ron Gold, Panda Irishman, Cruz-Midway, Thea, and Quartz Mountain.

Payment received from Rise Resources includes $50,000 in cash, and payment of 1,500,000 Rise shares and 1,500,000 Rise warrants to purchase 1,500,000 shares with an exercise price of $0.227 per warrant share until July 13, 2018 (collectively the “First Closing”). The common shares now owned by Klondike represent 4.56% of Rise’s issued and outstanding on closing.

To complete the acquisition of 100% of the properties, Rise Resources must make a further payment upon the one year anniversary of First Closing of $150,000 in cash, and payment of 2,000,000 Rise shares and 1,000,000 Rise warrants to purchase 1,000,000 shares for a period of 24 months (collectively the “Second Closing”).

Klondike Gold will retain a 2.0% NSR and Rise will have the right to purchase 50% of this royalty for $1.0 million at any time after the First Closing.

Peter Tallman, President and CEO of Klondike states, “Klondike has divested its interests in southeastern British Columbia in return for a meaningful share position in Rise Resources while retaining a royalty interest. This strategy allows Klondike Gold shareholders significant leverage to a portfolio of highly prospective British Columbia gold and base metal properties while keeping the Company’s financial and exploration focus on its core Yukon assets. We welcome Rise Resources as our partner in realizing value from these properties for both our Companies.”

ABOUT KLONDIKE GOLD CORP.

Klondike Gold Corp. is a Canadian exploration company with offices in Vancouver, British Columbia, and Dawson City, Yukon Territory. The company is focused on exploration and development of its Yukon gold projects, accessible by government maintained roads located on the outskirts of Dawson City, YT, covering 308 square kilometers of hard rock and 20 square kilometers of placer claims including “McKinnon Creek” featured on the Discovery Channel show “Gold Rush”.

On behalf of Klondike Gold Corp.

“Peter Tallman”
President and CEO
(604) 609-6110
E-mail: info@klondikegoldcorp.com
Website: www.klondikegoldcorp.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclaimer for Forward-Looking Information

This press release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable securities laws. This information and statements address future activities, events, plans, developments and projections. All statements, other than statements of historical fact, constitute forward-looking statements or forward-looking information. Such forward-looking information and statements are frequently identified by words such as “may,” “will,” “should,” “anticipate,” “plan,” “expect,” “believe,” “estimate,” “intend” and similar terminology, and reflect assumptions, estimates, opinions and analysis made by management of Klondike in light of its experience, current conditions, expectations of future developments and other factors which it believes to be reasonable and relevant. Forward-looking information and statements involve known and unknown risks and uncertainties that may cause Klondike’s actual results, performance and achievements to differ materially from those expressed or implied by the forward-looking information and statements and accordingly, undue reliance should not be placed thereon.

Risks and uncertainties that may cause actual results to vary include but are not limited to the availability of financing; fluctuations in commodity prices; changes to and compliance with applicable laws and regulations, including environmental laws and obtaining requisite permits; political, economic and other risks; as well as other risks and uncertainties which are more fully described in our annual and quarterly Management’s Discussion and Analysis and in other filings made by us with Canadian securities regulatory authorities and available at www.sedar.com. Klondike disclaims any obligation to update or revise any forward-looking information or statements except as may be required.

SOURCE: Klondike Gold Corp.

ReleaseID: 442466

EliteSupplementReviews.com will Feature In-Depth and Helpful Reviews of Some of the Most Popular Health and Wellness Products

LOS ANGELES, CA / ACCESSWIRE / July 18, 2016 / The founders of EliteSupplementReviews.com, a website that will feature thorough reviews of some of the top health and wellness products, are pleased to announce the launch of their new and user-friendly website.

As a company spokesperson noted, one of the first reviews to be posted on the website is already creating quite a buzz with visitors. Titled “Leptigen Review,” the article offers both a case study and in-depth review of the product.

According to the review, Leptigen is a clinically studied weight loss supplement that uses a proprietary blend of ingredients to facilitate healthy, safe weight loss. Since it first hit the market, it has become one of the best selling weight loss supplements that is available.

As the new review notes, Leptigen works by using thermogenic and lipolysis-inducing agents. What this means in plain English, the author notes, is that it is designed to boost the body’s metabolism and also helps the body to burn fat more easily.

Leptigen contains four main ingredients: Meratrim, ChromeMate, Green Tea Extract and Caffeine. As the review notes, this quartet of supplements and ingredients work in their own unique ways to help people boost their metabolism and lose weight.

While thousands of adults have used Leptigen successfully, people who are sensitive to caffeine should use caution before trying it.

“The only concern with Leptigen is the use of caffeine in the formula,” the review noted, adding that the caffeine is little more than what is found in two cups of coffee. “If you are sensitive to caffeine, then you may experience jittery, uneasy feelings. But for 99 percent of users, there are no side effects.”

Overall, noted the review, Leptigen appears to be “the real deal” in the crowded world of weight loss supplements.

“Its ingredients are backed by actual science and user testimonials are mostly positive. Based on this information, it’s safe to say this product is a legitimate supplement that can and will help you lose weight.”

Anybody who would like to learn more about EliteSupplementReviews.com is welcome to visit the user-friendly website at any time; there, they can read the recent review of Leptigen in its entirety.

About EliteSupplementReviews.com:

EliteSupplementReviews.com is a new website on the hunt for the best natural health and wellness products to review. For more information, please go to their website at: http://elitesupplementreviews.com/.

Contact:

Johnathan Saunders
admin@rocketfactor.com
(949) 555-2861

SOURCE: EliteSupplementReviews.com

ReleaseID: 442504

NEW YORK, NY / ACCESSWIRE / July 18, 2016 / SeeThruEquity, the leading independent equity research firm focused on smallcap and microcap public companies, today announced it has issued an update on CytoDyn Inc. (OTCQB: CYDY) with a price target of $3.40.

The report is available here: CYDY Update Note. 

CytoDyn Inc. (OTCQB: CYDY, “CytoDyn”) is engaged in the development of humanized monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV), and other diseases. CytoDyn’s lead drug candidate is PRO-140, a viral entry inhibitor which seeks to block HIV from entering a cell by binding to a molecule called CCR5. CytoDyn has a Phase 3 clinical trial underway with PRO-140 for HIV in combination with Highly Active Anti-Retroviral Therapy (HAART). The company also recently initiated a Phase 3 trial of PRO-140 for long-term monotherapy as a replacement for HAART for patients who have completed initial antiretroviral therapy (ART). If approved, PRO-140 would be the first, self-administered, injectable antibody therapy for HIV. In our view, whether approved as a combination therapy or first line therapy, PRO-140 has the potential to be a significant advancement in the treatment of HIV, which could dramatically improve the quality of life for HIV patients while sharply lowering toxicity, offering fewer side-effects, and lowering costs versus existing treatments.

Investment Highlights

Positive Clinical Developments

CytoDyn held an update conference call with investors on July 13, 2016, during which the company announced several key developments on the clinical front. These included an important outcome from its conversations with the FDA regarding its ongoing Phase 3 clinical trial for PRO-140 in combination therapy with HAART, which allows for an accelerated and less costly completion of the trial, as well as the introduction of a new clinical pathway for PRO-140 with the potential for breakthrough and orphan drug designations. Finally, while no specific timing was provided, the company reiterated that achieving an uplisting to the NASDAQ or NYSE Market was a high priority for the company.

FDA allows CYDY to trim patient enrollment pool to 150

In a significant development for what is likely CytoDyn’s best chance for an approval of PRO-140, the FDA allowed the company to reduce its enrollment pool by half in its ongoing Phase 3 pivotal study of PRO-140 as a 2nd line combination therapy with HAART. This should allow CytoDyn to accelerate the timeline for the trial. It will also reduce costs given that fewer patients will be participating in the 25-week trial, which has a primary endpoint of viral load reduction from baseline and secondary endpoints of tolerating repeat subcutaneous injections with no serious adverse events related to PRO-140 over 24 weeks. If approved, the potential market opportunity for PRO-140 for 2nd line combination therapy with HAART is estimated to be approximately $5 billion per year.

CYDY identifies new potential pathway for acute HIV

A key takeaway for us from CYDY’s investor update was that management believes it has identified a new potential pathway for PRO-140, which has the potential for breakthrough status and may qualify for an orphan drug designation. The pathway involves initiating PRO-140 therapy for treatment-naïve HIV patients in the two week “danger period” while they wait for the results of a genotype test that enables physicians to select the best medication for patients. For these two weeks the patient has no available drugs, making HIV an acute condition. CYDY expects to file an application for a Phase 2b clinical study with the FDA within a week’s time, and we are eager to learn more about the size and scope of this this opportunity.

Maintaining price target of $3.40

We are maintaining our price target for CYDY at this time. We continue to see CYDY as a speculative biotechnology company with a bold goal of transforming the quality of life for HIV patients in the United States.

Please review important disclosures at www.seethruequity.com. 

About CytoDyn Inc.

CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV infection. The Company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has completed Phase 2 clinical trials with demonstrated antiviral activity in man and is currently in Phase 3. PRO 140 blocks the HIV co-receptor CCR5 on T cells, which prevents viral entry. Clinical trial results thus far indicate that PRO 140 does not negatively affect the normal immune functions that are mediated by CCR5. Results from seven Phase 1 and Phase 2 human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. A recent Phase 2b clinical trial demonstrated that PRO 140 can prevent viral escape in patients during several weeks of interruption from conventional drug therapy. CytoDyn intends to continue to develop PRO 140 as a therapeutic anti-viral agent in persons infected with HIV and to pursue non-HIV indications where CCR5 and its ligand CCL5 may be involved. www.cytodyn.com.

About SeeThruEquity

Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative business model for equity research that is not paid for and is unbiased. SeeThruEquity is the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry’s most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.
For more information visit www.seethruequity.com.

Contact:

SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 442497

NEW YORK, NY / ACCESSWIRE / July 18, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of Cellectar Biosciences, Inc. (NASDAQ: CLRB).

The report is available here: CLRB Initiation Report.

Based in Madison, WI, Cellectar is an oncology-focused clinical-stage biotechnology company. Cellectar is developing a pipeline of products for the treatment and imaging of cancer, using its proprietary Phospholipid Drug Conjugate (PDC) Delivery Platform. The company’s patented PDC Delivery Platform is a phospholipid ether cancer-targeting vehicle, which promises to enable the delivery of “diverse oncologic payloads” including cytotoxic small molecules directly to cancer cells. Cellectar’s proprietary PDCs offer both highly selective targeting and prolonged retention in a wide range of cancer and cancer stem cells. Importantly, the key differentiating claim that Cellectar makes regarding its PDCs versus other chemotherapeutics is that PDCs’ cancer-targeting capabilities limit a drug’s exposure to healthy cells. This will potentially increase the potency of drugs at lower concentrations and thereby increase the payload therapeutic window.

“Cellectar’s lead candidate using PDC is CLR-131, a Phase 1 candidate for the treatment of multiple myeloma. Cellectar intends for PDC to serve as a platform technology, which can be used to address many cancer types. We would expect the company to pursue a strategy in which it demonstrates the effectiveness of the platform with initial candidates covering a diverse group of payloads. Then we would expect Cellectar to advance new indications though strategic partnerships with larger pharmaceutical companies better equipped to fully fund new drug development. In our view, Cellectar is a speculative company in the biotechnology sector with the potential to develop and commercialize an impactful new cancer targeting and payload delivery technology in the large and growing market for oncology therapeutics,” commented Ajay Tandon, CEO of SeeThruEquity. “We initiate coverage on Cellectar with a price target of $7.44.”

Additional highlights from the initiation report are as follows:

Proprietary PDC delivery technology a significant opportunity

At the core of Cellectar’s value proposition is the company’s proprietary Phospholipid Ether Drug Conjugate (PDC) Delivery Platform. The PDC Delivery Platform holds significant promise, having demonstrated selective targeting of cancer and cancer stem cells (CSC) in 70+ in vivo cancer models and on over 80 patients with 10+ types of cancer. With its targeted delivery, PDCs have the potential to improve the therapeutic index of drug payloads – maintaining and potentially enhancing efficacy, while reducing adverse events by minimizing drug delivery to healthy cells. If the company is successful in showing that PDCs can target multiple cancers and be effective with a variety of payloads, it should dramatically expand its potential in the $100+ billion cancer drug market.

Data, collaborative partners add scientific validation

PDCs are proprietary to Cellectar, and are supported by extensive IP. The potential of the technology has been validated not only in preclinical studies but also by the company’s collaborative partnership with Pierre Fabre Pharmaceuticals – the third largest pharmaceutical company in France. This is an impressive strategic relationship, in our view, as the companies will work together in a research capacity to develop a variety of cancer treatments using Cellectar’s proprietary PDC small molecule cancer-targeting delivery platform and Pierre Fabre’s payloads comprising natural product-derived cytotoxics, so that the companies can jointly develop a library of targeted PDCs with enhanced therapeutic potential.

Additionally, we are encouraged by the progress made by the company on its drug candidate pipeline. Its lead candidate, CLR-131 for multiple myeloma, was awarded an orphan drug designation by the FDA and is in the midst of a Phase 1 trial, with an update from the second cohort expected in 3Q16. Additionally, Cellectar recently reported positive data from its preclinical study of its paclitaxel chemotherapeutic conjugate, CLR-1602, which showed that the tumor uptake of CLR-1602’s paclitaxel payload increased by more than 30x over free paclitaxel half-life relative to free paclitaxel.

Please review important disclosures at www.seethruequity.com.

About Cellectar Biosciences, Inc.

Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. Cellectar’s PDC Delivery Platform is based on the company’s proprietary phospholipid ether analogs. These novel small-molecules have demonstrated highly selective uptake and retention in a broad range of cancers. Cellectar’s PDC pipeline includes product candidates for cancer therapy and cancer diagnostic imaging. The company’s lead therapeutic PDC, CLR 131, utilizes iodine-131, a cytotoxic radioisotope, as its payload. CLR 131 is currently being evaluated under an orphan drug designated Phase 1 study in patients with relapsed or refractory multiple myeloma. The company is also developing PDCs for targeted delivery of chemotherapeutics such as paclitaxel (CLR 1603-PTX), a preclinical stage product candidate, and plans to expand its PDC chemotherapeutic pipeline through both in-house and collaborative R&D efforts. For additional information please visit www.cellectarbiosciences.com.

About SeeThruEquity

Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative business model for equity research that is not paid for and is unbiased. SeeThruEquity is the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry’s most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.

For more information, visit www.seethruequity.com.

Contact:

Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 442511